{
    "nct_id": "NCT05183854",
    "official_title": "Phase II Study of the Efficacy of the Pneumococcal Pneumonia Vaccine Series in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency (PROTECT CLL)",
    "inclusion_criteria": "* NAIVE COHORT: Subjects must have a confirmed diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (collectively referred to as CLL throughout) according to the 2018 International Workshop on CLL.\n* NAIVE COHORT: Male or female subject aged >= 18 years.\n* NAIVE COHORT: Subjects must not have received prior therapy for CLL.\n* VENETOCLAX-TREATMENT COHORT: Subjects must have a confirmed diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (collectively referred to as CLL throughout) according to the 2018 International Workshop on CLL.\n* VENETOCLAX-TREATMENT COHORT: Subjects must have received venetoclax (any dose) for at least 12 months with the last dose =< 12 months prior to registration.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Subjects who have experienced a severe allergic reaction to prior pneumococcal vaccination.\n* Subjects who have received a PCV13 or PCV20 pneumococcal vaccination in the last five years.\n* If they have received PPSV23 in â‰¥ 1 year and no other pneumococcal vaccine they may be included.\n* Active infection requiring systemic antibiotic therapy.\n* Current or prior use of immunosuppressive medication within 14 days of cycle one day one, EXCEPT for the following permitted steroids:\n\n  * Intranasal, inhaled, topical steroids, eye drops or local steroid injection (e.g., intra-articular injection);\n  * Systemic corticosteroids at physiologic doses =< 10 mg/day of prednisone or equivalent;\n  * Steroids as premedication for hypersensitivity reactions (e.g., computed tomography [CT] scan premedication).\n* Concurrent illness or condition, which, in the opinion of the treating investigator, would negatively impact the subject's study participation.",
    "miscellaneous_criteria": ""
}